MiR-96 is a potent oncomiR, which increases NSCLC chemoresistance by reducing the expression of Sterile Alpha Motif Domain Containing 9 (SAMD9) [58]. This evidence concerns the gene SAMD9 and non-small cell lung carcinoma.